SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-000392
Filing Date
2024-02-01
Accepted
2024-02-01 16:44:11
Documents
1
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3680
  Complete submission text file 0000905148-24-000392.txt   5108
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEXTCURE, INC. 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address
Langermann Sol (Reporting) CIK: 0001775459 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38905 | Film No.: 24587581